drug

peginterferon alfa-2a

1 story · latest Oct 20, 2026

Follow peginterferon alfa-2a. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Oct 2002 · BLA103964
Brand: Pegasys

Timeline

FDA approves GSK's Hibsago for chronic hepatitis B

Oct 20Regulatory decisionbepirovirsen GlaxoSmithKline

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.